• SENSEX 76,059.77
    -331.62 (--0.43%)
  • BANKNIFTY 56,693.50
    101.50 (+0.18%)
  • HCL Technologies
    1,275.50 1,770.00(%)
  • Shadowfax Technologies
    203.85 98.60(%)
  • Infosys
    1,014.15 984.00(%)
  • Bluestone Jewel
    793.45 872.60(%)
  • Bajaj Finance
    1,002.00 788.40(%)
  • HDFC Bank
    737.20 726.75(%)
  • Caliber Mining
    538.15 538.15(%)
  • E2E Networks
    516.95 516.95(%)
  • Coforge
    1,488.00 1,988.90(%)
  • ICICI Pru Life
    495.55 459.60(%)
  • SBI
    1,018.00 1,234.80(%)
  • AU Small Finance
    1,015.00 1,090.40(%)
  • SRF
    2,697.50 3,257.95(%)
  • Shriram Finance
    992.75 566.40(%)
  • Maruti Suzuki
    13,498.95 17,371.60(%)
  • B H E L
    418.00 446.75(%)
  • CG Power & Ind
    839.25 525.50(%)
  • Interglobe Aviat
    4,886.70 3,894.80(%)
  • Power Grid Corpn
    285.65 250.05(%)
  • Five-Star Bus.Fi
    537.45 733.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenith Drugs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013
49.25 0 (0.61%)
  • As on 24 Jul 2026 (EOD)

  • Today’s Low

    49.00

  • Today’s High

    49.25

  • Open

    49.00

  • Perv Close

    48.95

  • 52W Low

    33.30

  • 52W High

    76.00

Key Indicators

  • P/E(TTM)

    20.35

  • Mar.Cap (₹Cr.)

    84.46

  • Div & Yield %

    0.00

  • Book Value(₹)

    43.69

  • Debt-Equity Ratio

    0.61

  • AGM Date

    24-Jul-2026

  • EPS

    2.42

  • P/E Ratio

    20.35

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    84.46

  • RONW (%)

    24.13

  • ROCE (%)

    25.16

Score Board

  • Equity (₹ in Cr.)

    17.15

  • BV (₹)

    43.70

  • Sales( ₹ in Cr.)

    171.22

  • NP (in Cr.)

    4.16

  • NP Var(%)

    -43.0

  • Div%

    0.0

  • CPS (₹)

    6.00

  • EPS (₹)

    2.40

  • Traded Value (₹ in Lakhs)

    84.46

  • 52 Week High

    76.00

  • 52 Week Low

    33.30

  • Price BSE

    0.0

  • Price NSE

    49.00

  • Market Capital( in Cr.)

    84.46

  • P/C Ratio

    8.20

  • P/E Ratio

    20.20

  • Price Vs.BV

    2.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 147.52 146.37 114.52 91.66 81.12 85.94
Excise Duty 14.20 14.75 0.00 0.00 7.72 7.67
Net Sales 133.32 131.62 114.52 91.66 73.40 78.27
Other Income 2.61 2.12 1.24 0.95 0.11 0.06
Stock Adjustments 0.59 -1.36 0.54 2.93 -0.16 -0.38
Total Income 136.52 132.38 116.30 95.54 73.35 77.95
EXPENDITURE :            
Raw Materials 52.76 36.41 0.00 75.44 47.69 53.64
Power and Fuel Cost 1.59 1.09 1.04 0.00 0.00 0.03
Employee Cost 6.76 5.34 4.96 2.98 2.41 3.00
Other Manufacturing Expenses 43.90 54.80 84.63 2.49 4.84 3.55
Selling and Administration Expenses 14.84 15.62 0.00 4.86 10.95 9.84
Miscellaneous Expenses 0.72 1.53 15.38 1.81 0.16 0.79
Employee Benefit Expenses 6.76 5.34 4.96 2.98 2.41 3.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 120.58 114.79 106.01 87.58 66.05 70.85
Operating Profit 15.94 17.59 10.29 7.95 7.31 7.11
Interest 3.71 3.00 2.33 2.21 1.49 1.31
Gross Profit 12.23 14.59 7.96 5.74 5.82 5.80
Depreciation 2.97 1.30 1.30 1.34 1.22 0.92
Profit Before Tax 9.26 13.29 6.66 4.40 4.60 4.88
Current Tax 2.05 3.99 1.83 1.24 1.36 1.51
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 -0.24 -0.05 -0.05 0.17 -0.04
Reported Net Profit 7.16 9.54 4.88 3.21 3.07 3.40
Extraordinary Items -0.15 -1.11 0.00 0.00 0.00 0.01
Adjusted Net Profit 7.31 10.65 4.88 3.21 3.07 3.39
Adjustment below Net Profit 0.00 -11.40 -4.88 0.00 0.00 0.00
P & L Balance brought forward 14.41 17.13 0.00 9.04 5.97 2.57
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.86 0.00 0.00 0.00 0.00
P & L Balance carried down 21.57 14.41 0.00 12.25 9.04 5.97
Dividend 0.00 0.86 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 5.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.50 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.18 5.56 122.03 80.32 76.66 85.00
Earnings Per Share(Adj)-Unit Curr 4.18 5.56 - - - -
Book Value 40.46 36.28 443.30 321.27 240.95 164.29
Book Value(Adj)-Unit Curr 40.46 36.28 - - - -

Shareholding Pattern

  • Promoter Group

    69.98%

  • Public Share Holding

    30.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,000,000 69.98 12,000,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,000,000 69.98 12,000,000 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 545,200 3.18 545,200 29
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 91,200 0.53 91,200 25
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 178,400 1.04 178,400 67
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,275,200 7.44 1,275,200 17
Individuals holding nominal share capital up to Rs. 1 lakh 2,965,600 17.29 2,965,600 1,288
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 93,200 0.54 93,200 2
Sub Total 5,148,800 30.02 5,148,800 1,428
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,148,800 100.00 17,148,800 1,435

Company Background

Zenith Drugs LtdPharmaceuticals - Indian - Formulations

  • Zenith Drugs Ltd
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013

  • Incorporation Year

    2000

  • Registered Office

    K # 72/5 Village Muradpura
    NA Depalpur, Indore,
    Madhya Pradesh-453001

  • Telephone

    +91 84355 01867

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Sakshi Bhawsar

  • Auditor

    VDS & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Zenith Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenith Drugs 49.25 135.93 147.52 21.41 12.71
Abbott India 28,003.45 7,217.19 6,929.05 38.34 43.78
Astrazeneca Phar 8,000.10 2,304.07 2,275.58 106.65 27.86
P & G Health Ltd 6,723.60 944.52 934.17 34.14 71.75
Glaxosmi. Pharma 2,513.25 3,932.76 3,790.20 42.08 58.17
Cipla 1,410.90 20,102.60 18,979.95 37.08 13.88
Amrutanjan Healt 510.50 469.50 451.82 25.49 21.89
Bliss GVS Pharma 463.55 773.53 729.81 50.77 12.51
Fermenta Biotec. 432.60 474.15 450.25 19.81 18.77
Guj. Themis Bio. 360.50 152.47 150.80 84.23 27.21
Ambalal Sarabhai 32.45 19.52 3.94 22.69 6.77